title: [Renal function after nephrectomy for Wilms' tumor].
abstract: BACKGROUND
  Most children with Wilms tumour recover after nephrectomy, chemotherapy and sometimes radiotherapy. It is therefore important to assess their long-term renal function.
  
  
  METHODS
  Thirty-three patients with Wilms tumour experienced unilateral nephrectomy between 1986 and 1993: three were excluded; 23 were staged as grade I, one at grade II, two at grade III and four at grade IV. They were treated with SIOP 6 and SIOP 9 protocols. The results were compared to five controls who underwent unilateral nephrectomy including three for renal trauma. The glomerular filtration rate (GFR) was measured by inulin clearance and the renal plasma flow (RPF) by para-amino-hippuric acid clearance.
  
  
  RESULTS
  The mean age at nephrectomy was 3.4 +/- 2.5 years (median: 3, range: 0.2-10.6) and the duration of follow-up was 4.6 +/- 3.1 years (median: 4.5, range: 1-8.5), the GFR was 93 +/- 13 mL/min/1.73 m2 (median: 93, range: 73-130), the RPF was 441 +/- 85 mL/min/1.73 m2 (median: 453, range: 236-650) and the filtrated fraction (FF) was 0.21 +/- 0.03 (median: 0.20, range: 0.18-0.31). The difference in renal function between patients and controls was not significant (GRF: 86 +/- 12 mL/min/1.73 m2, RPF: 486 +/- 185 mL/min/1.73 m2, FF: 0.22 +/- 0.03). The electrolyte reabsorption rate was normal and none of the patients suffered from arterial hypertension. Fourteen children had urinary albumin: creatinine ratio > 2 g/mol. When comparing patients according to the duration of follow-up after nephrectomy (< 4 years vs > 4 years), the renal function was not statistically different. The age at nephrectomy (< 2 years vs > 2 years) did not increase the risk of renal impairment.
  
  
  CONCLUSIONS
  Children with Wilms tumour who were treated with nephrectomy and non-nephrotoxic drugs (actinomycin, vincristine, epiadriamycin) have a good long-term renal outcome. It is speculated that systematic renal investigation should be limited to those children with increased microalbuminuria and/or elevated blood pressure.
authors.affiliation: Unité de néphrologie pédiatrique, hôpital Edouard-Herriot, Lyon, France.
authors.forename: C
authors.initials: C
authors.lastname: Chevallier
authors.forename: A
authors.initials: A
authors.lastname: Hadj-Aïssa
authors.forename: M
authors.initials: M
authors.lastname: Brunat-Mentigny
authors.forename: G
authors.initials: G
authors.lastname: Faraj
authors.forename: M
authors.initials: M
authors.lastname: Schell
authors.forename: P
authors.initials: P
authors.lastname: Cochat
mesh_terms: D000704:Analysis of Variance; D002648:Child; D002675:Child, Preschool; D005919:Glomerular Filtration Rate; D006801:Humans; D007223:Infant; D007677:Kidney Function Tests; D007680:Kidney Neoplasms / Q000601:surgery*; D009392:Nephrectomy; D010710:Phosphates / Q000493:pharmacokinetics; D011184:Postoperative Period; D017595:Renal Plasma Flow; D012964:Sodium / Q000493:pharmacokinetics; D009396:Wilms Tumor / Q000601:surgery*
chemical_list: D010710:Phosphates; D012964:Sodium